Wixela Inhub Generic and Brand Name
Wixela Inhub is the brand name, and the generic name is fluticasone propionate and salmeterol inhalation powder 1.
Key Nomenclature Details
Generic Components:
- Fluticasone propionate (corticosteroid)
- Salmeterol (long-acting beta-agonist)
Brand Name:
- Wixela Inhub® (registered trademark of Mylan Pharmaceuticals Inc., a Viatris Company)
Important Context
Wixela Inhub is FDA-approved as a generic equivalent to Advair Diskus (the original brand-name product manufactured by GlaxoSmithKline) 2, 3. Both products deliver the same active pharmaceutical ingredients—fluticasone propionate and salmeterol—as a fixed-dose combination dry powder inhaler 1.
Available Strengths
The product comes in three strength combinations 1:
- 100/50 mcg (100 mcg fluticasone propionate/50 mcg salmeterol)
- 250/50 mcg (250 mcg fluticasone propionate/50 mcg salmeterol)
- 500/50 mcg (500 mcg fluticasone propionate/50 mcg salmeterol)
Clinical Equivalence
Bioequivalence studies have demonstrated that Wixela Inhub is therapeutically equivalent to Advair Diskus for both asthma and COPD treatment 3, 4. Real-world evidence from over 45,000 COPD patients showed nearly identical outcomes between generic Wixela Inhub and brand-name Advair Diskus for both effectiveness (COPD exacerbations) and safety (pneumonia hospitalizations) 4.